{"count": 6, "results": [{"_id": "37702819", "pmid": 37702819, "pmcid": "PMC10713903", "title": "Metformin combined with rapamycin ameliorates podocyte injury in idiopathic membranous nephropathy through the AMPK/mTOR signaling pathway", "journal": "J Cell Commun Signal", "authors": ["Ma M", "Pan Y", "Zhang Y", "Yang M", "Xi Y", "Lin B", "Hao W", "Liu J", "Wu L", "Liu Y", "Qin X"], "date": "2023-09-13T00:00:00Z", "doi": "10.1007/s12079-023-00781-8", "meta_date_publication": "2023 Sep 13", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50259.25, "text_hl": "However, the therapeutic mechanisms of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Sirolimus @CHEMICAL_MESH:D020123 @@@rapamycin@@@ in @<m>DISEASE_Glomerulonephritis_Membranous</m> @DISEASE_MESH:D015433 @@@IMN@@@ remain unclear. ", "citations": {"NLM": "Ma M, Pan Y, Zhang Y, Yang M, Xi Y, Lin B, Hao W, Liu J, Wu L, Liu Y, Qin X. Metformin combined with rapamycin ameliorates podocyte injury in idiopathic membranous nephropathy through the AMPK/mTOR signaling pathway J Cell Commun Signal. 2023 Sep 13;():. PMID: 37702819", "BibTeX": "@article{37702819, title={Metformin combined with rapamycin ameliorates podocyte injury in idiopathic membranous nephropathy through the AMPK/mTOR signaling pathway}, author={Ma M and Pan Y and Zhang Y and Yang M and Xi Y and Lin B and Hao W and Liu J and Wu L and Liu Y and Qin X}, journal={J Cell Commun Signal}}"}}, {"_id": "32540980", "pmid": 32540980, "title": "Metformin Suppresses Development of the Echinococcus multilocularis Larval Stage by Targeting the TOR Pathway.", "journal": "Antimicrob Agents Chemother", "authors": ["Loos JA", "Dávila VA", "Brehm K", "Cumino AC"], "date": "2020-08-20T00:00:00Z", "doi": "10.1128/AAC.01808-19", "meta_date_publication": "2020 Aug 20", "meta_volume": "64", "meta_issue": "9", "meta_pages": "", "score": 50251.21, "text_hl": "Our results revealed @<m>DISEASE_Glomerulonephritis_Membranous</m> @DISEASE_MESH:D015433 @@@mitochondrial membrane@@@ depolarization, activation of Em-AMPK, suppression of Em-TOR, and overexpression of Em-@GENE_MAP1LC3B @GENE_67443 @@@Atg8@@@ in the germinal layer of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-treated metacestode vesicles. ", "citations": {"NLM": "Loos JA, Dávila VA, Brehm K, Cumino AC. Metformin Suppresses Development of the Echinococcus multilocularis Larval Stage by Targeting the TOR Pathway. Antimicrob Agents Chemother. 2020 Aug 20;64(9):. PMID: 32540980", "BibTeX": "@article{32540980, title={Metformin Suppresses Development of the Echinococcus multilocularis Larval Stage by Targeting the TOR Pathway.}, author={Loos JA and Dávila VA and Brehm K and Cumino AC}, journal={Antimicrob Agents Chemother}, volume={64}, number={9}}"}}, {"_id": "40106213", "pmid": 40106213, "title": "Targeting autophagy in autoimmune glomerular diseases.", "journal": "J Nephrol", "authors": ["Claudio P", "Gabriella M"], "date": "2025-03-19T00:00:00Z", "doi": "10.1007/s40620-025-02267-9", "meta_date_publication": "2025 Mar 19", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50238.65, "text_hl": "Drugs that improve mitochondrial function or enhance autophagy, such as @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @GENE_SLC5A2 @GENE_6524 @@@sodium-glucose co-transporter 2@@@ (@GENE_SLC5A2 @GENE_6524 @@@SGLT2@@@) inhibitors or @GENE_MTOR @GENE_2475 @@@mTOR@@@ inhibitors, may exert protective effects on podocytes and reduce @DISEASE_Proteinuria @DISEASE_MESH:D011507 @@@proteinuria@@@ in @<m>DISEASE_Glomerulonephritis_Membranous</m> @DISEASE_MESH:D015433 @@@MN@@@ or @DISEASE_Glomerulosclerosis_Focal_Segmental @DISEASE_MESH:D005923 @@@focal segmental glomerulosclerosis@@@ (@DISEASE_Glomerulosclerosis_Focal_Segmental @DISEASE_MESH:D005923 @@@FSGS@@@).", "citations": {"NLM": "Claudio P, Gabriella M. Targeting autophagy in autoimmune glomerular diseases. J Nephrol. 2025 Mar 19;():. PMID: 40106213", "BibTeX": "@article{40106213, title={Targeting autophagy in autoimmune glomerular diseases.}, author={Claudio P and Gabriella M}, journal={J Nephrol}}"}}, {"_id": "21806981", "pmid": 21806981, "title": "In vitro and in vivo anti-melanoma action of metformin.", "journal": "Eur J Pharmacol", "authors": ["Janjetovic K", "Harhaji-Trajkovic L", "Misirkic-Marjanovic M", "Vucicevic L", "Stevanovic D", "Zogovic N", "Sumarac-Dumanovic M", "Micic D", "Trajkovic V"], "date": "2011-10-15T00:00:00Z", "doi": "10.1016/j.ejphar.2011.07.004", "meta_date_publication": "2011 Oct 15", "meta_volume": "668", "meta_issue": "3", "meta_pages": "373-82", "score": 50052.68, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-mediated apoptosis of @DISEASE_Melanoma @DISEASE_MESH:D008545 @@@melanoma@@@ cells was preceded by induction of oxidative stress and mitochondrial @<m>DISEASE_Glomerulonephritis_Membranous</m> @DISEASE_MESH:D015433 @@@membrane@@@ depolarization, measured by flow cytometry in cells stained with appropriate fluorescent reporter dyes. ", "citations": {"NLM": "Janjetovic K, Harhaji-Trajkovic L, Misirkic-Marjanovic M, Vucicevic L, Stevanovic D, Zogovic N, Sumarac-Dumanovic M, Micic D, Trajkovic V. In vitro and in vivo anti-melanoma action of metformin. Eur J Pharmacol. 2011 Oct 15;668(3):373-82. PMID: 21806981", "BibTeX": "@article{21806981, title={In vitro and in vivo anti-melanoma action of metformin.}, author={Janjetovic K and Harhaji-Trajkovic L and Misirkic-Marjanovic M and Vucicevic L and Stevanovic D and Zogovic N and Sumarac-Dumanovic M and Micic D and Trajkovic V}, journal={Eur J Pharmacol}, volume={668}, number={3}, pages={373-82}}"}}, {"_id": "27225841", "pmid": 27225841, "title": "Metformin Protects Cells from Mutant Huntingtin Toxicity Through Activation of AMPK and Modulation of Mitochondrial Dynamics.", "journal": "Neuromolecular Med", "authors": ["Jin J", "Gu H", "Anders NM", "Ren T", "Jiang M", "Tao M", "Peng Q", "Rudek MA", "Duan W"], "date": "2016-12-01T00:00:00Z", "doi": "10.1007/s12017-016-8412-z", "meta_date_publication": "2016 Dec", "meta_volume": "18", "meta_issue": "4", "meta_pages": "581-592", "score": 50047.277, "text_hl": "Furthermore, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment prevented @<m>DISEASE_Glomerulonephritis_Membranous</m> @DISEASE_MESH:D015433 @@@mitochondrial membrane depolarization@@@ and excess fission and modulated the disturbed mitochondrial dynamics in @DISEASE_Huntington_Disease @DISEASE_MESH:D006816 @@@HD@@@ cells. ", "citations": {"NLM": "Jin J, Gu H, Anders NM, Ren T, Jiang M, Tao M, Peng Q, Rudek MA, Duan W. Metformin Protects Cells from Mutant Huntingtin Toxicity Through Activation of AMPK and Modulation of Mitochondrial Dynamics. Neuromolecular Med. 2016 Dec;18(4):581-592. PMID: 27225841", "BibTeX": "@article{27225841, title={Metformin Protects Cells from Mutant Huntingtin Toxicity Through Activation of AMPK and Modulation of Mitochondrial Dynamics.}, author={Jin J and Gu H and Anders NM and Ren T and Jiang M and Tao M and Peng Q and Rudek MA and Duan W}, journal={Neuromolecular Med}, volume={18}, number={4}, pages={581-592}}"}}, {"_id": "30102470", "pmid": 30102470, "title": "Synchronized Ratiometric Codelivery of Metformin and Topotecan through Engineered Nanocarrier Facilitates In Vivo Synergistic Precision Levels at Tumor Site.", "journal": "Adv Healthc Mater", "authors": ["Banala VT", "Sharma S", "Barnwal P", "Urandur S", "Shukla RP", "Ahmad N", "Mittapelly N", "Pandey G", "Dwivedi M", "Kalleti N", "Mitra K", "Rath SK", "Trivedi R", "Mishra PR"], "date": "2018-10-01T00:00:00Z", "doi": "10.1002/adhm.201800300", "meta_date_publication": "2018 Oct", "meta_volume": "7", "meta_issue": "19", "meta_pages": "e1800300", "score": 50045.496, "text_hl": "Coloaded @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ and @CHEMICAL_Topotecan @CHEMICAL_MESH:D019772 @@@TPT@@@ LB-MSNs present synergistic @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@cytotoxicity@@@ against @CELLLINE_CVCL:YA89 @@@MDA-MB-231/4T1@@@ cells and effectively promote apoptosis via @<m>DISEASE_Glomerulonephritis_Membranous</m> @DISEASE_MESH:D015433 @@@mitochondrial membrane@@@ depolarization and cell cycle arrest. ", "citations": {"NLM": "Banala VT, Sharma S, Barnwal P, Urandur S, Shukla RP, Ahmad N, Mittapelly N, Pandey G, Dwivedi M, Kalleti N, Mitra K, Rath SK, Trivedi R, Mishra PR. Synchronized Ratiometric Codelivery of Metformin and Topotecan through Engineered Nanocarrier Facilitates In Vivo Synergistic Precision Levels at Tumor Site. Adv Healthc Mater. 2018 Oct;7(19):e1800300. PMID: 30102470", "BibTeX": "@article{30102470, title={Synchronized Ratiometric Codelivery of Metformin and Topotecan through Engineered Nanocarrier Facilitates In Vivo Synergistic Precision Levels at Tumor Site.}, author={Banala VT and Sharma S and Barnwal P and Urandur S and Shukla RP and Ahmad N and Mittapelly N and Pandey G and Dwivedi M and Kalleti N and Mitra K and Rath SK and Trivedi R and Mishra PR}, journal={Adv Healthc Mater}, volume={7}, number={19}, pages={e1800300}}"}}]}